Abstract
We investigated the effects of the autophagy inhibitor hydroxychloroquine (HCQ) on cell death of cytosine arabinoside (Ara-C)-resistant human acute myeloid leukemia (AML) cells. Ara-C-sensitive (U937, AML-2) and Ara-C-resistant (U937/AR, AML-2/AR) human AML cell lines were used to evaluate HCQ-regulated cytotoxicity, autophagy, and apoptosis as well as effects on cell death-related signaling pathways. We found that HCQ-induced dose- and time-dependent cell death in Ara-C-resistant cells compared to Ara-C-sensitive cell lines. The extent of cell death and features of HCQ-induced autophagic markers including increase in microtubule-associated protein light chain 3 (LC3) I conversion to LC3-II, beclin-1, ATG5, as well as green fluorescent protein-LC3 positive puncta and autophagosome were remarkably greater in U937/AR cells. Also, p62/SQSTM1 was increased in response to HCQ. p62/SQSTM1 protein interacts with both LC3-II and ubiquitin protein and is degraded in autophagosomes. Therefore, a reduction of p62/SQSTM1 indicates increased autophagic degradation, whereas an increase of p62/SQSTM1 by HCQ indicates inhibited autophagic degradation. Knock down of p62/SQSTM1 using siRNA were prevented the HCQ-induced LC3-II protein level as well as significantly reduced the HCQ-induced cell death in U937/AR cells. Also, apoptotic cell death and caspase activation in U937/AR cells were increased by HCQ, provided evidence that HCQ-induced autophagy blockade. Taken together, our data show that HCQ-induced apoptotic cell death in Ara-C-resistant AML cells through autophagy regulation.
Original language | English |
---|---|
Pages (from-to) | 87-96 |
Number of pages | 10 |
Journal | Biomedicine and Pharmacotherapy |
Volume | 73 |
DOIs | |
Publication status | Published - 2015 Jul 1 |
Bibliographical note
Funding Information:M.Y.H. was the principal investigator and takes primary responsibility for the paper. M.Y.H. conceived and designed the experiments. K.Y.D., J.H.K., and E.J.I. performed the laboratory work for this study. K.Y.D. and J.J.E. participated in the statistical analyses. C.J.W., K.Y.S., and K.J.S. contributed reagents/materials and coordinated the research. M.Y.H. and K.Y.D. wrote the paper. The authors report no potential conflicts of interest. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and funded by the Ministry of Education ( NRF-2012R1A1A2 009114 ), and supported by the Industry-University Cooperation Project ( Yuhan 2013-31-0179 ). The funders had no role in the study design, data collection and analyses, decision to publish, or manuscript preparation.
Publisher Copyright:
© 2015 Elsevier Masson SAS.
All Science Journal Classification (ASJC) codes
- Pharmacology